Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
HLA ; 2018 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-29943500

RESUMEN

Natural killer cells are thought to influence the outcome of hematopoietic stem cell transplant (HSCT), impacting on relapse, overall survival, graft versus host disease and the control of infection, in part through the complex interplay between the large and genetically diverse killer immunoglobulin-like receptor (KIR) family and their ligands. This study examined the relationship between KIR gene content and clinical outcomes including the control of opportunistic infections such as cytomegalovirus in the setting of human leucocyte antigen (HLA)-matched sibling HSCT in an Australian cohort. The presence of the KIR B haplotype which contain more activating receptors in the donor, in particular centromeric B haplotype genes (Cen-B), was associated with improved overall survival of patients with acute myeloid leukemia (AML) undergoing sibling HSCT and receiving myeloablative conditioning. Donor Cen-B haplotype was also associated with reduced acute graft versus host disease grades II-IV whereas donor telomeric-B haplotype was associated with decreased incidence of CMV reactivation. In contrast, we were not able to demonstrate a reduced rate of relapse when the donor had KIR Cen-B, however relapse with a donor Cen-A haplotype was a competing risk factor to poor overall survival. Here we show that the presence of donor activating KIR led to improved outcome for the patient, potentially through reduced relapse rates and decreased incidence of acute GvHD translating to improved overall survival. This article is protected by copyright. All rights reserved.

2.
Br J Pharmacol ; 170(3): 532-45, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23826915

RESUMEN

BACKGROUND AND PURPOSE: Paliperidone is an active metabolite of the second-generation atypical antipsychotic, risperidone recently approved for the treatment of schizophrenia and schizoaffective disorder. Because paliperidone differs from risperidone by only a single hydroxyl group, questions have been raised as to whether there are significant differences in the effects elicited between these two drugs. EXPERIMENTAL APPROACH: We compared the relative efficacies of paliperidone versus risperidone to regulate several cellular signalling pathways coupled to four selected GPCR targets that are important for either therapeutic or adverse effects: human dopamine D2 , human serotonin 2A receptor subtype (5-HT2A ), human serotonin 2C receptor subtype and human histamine H1 receptors. KEY RESULTS: Whereas the relative efficacies of paliperidone and risperidone were the same for some responses, significant differences were found for several receptor-signalling systems, with paliperidone having greater or less relative efficacy than risperidone depending upon the receptor-response pair. Interestingly, for 5-HT2A -mediated recruitment of ß-arrestin, 5-HT2A -mediated sensitization of ERK, and dopamine D2 -mediated sensitization of adenylyl cyclase signalling, both paliperidone and risperidone behaved as agonists. CONCLUSIONS AND IMPLICATIONS: These results suggest that the single hydroxyl group of paliperidone promotes receptor conformations that can differ from those of risperidone leading to differences in the spectrum of regulation of cellular signal transduction cascades. Such differences in signalling at the cellular level could lead to differences between paliperidone and risperidone in therapeutic efficacy or in the generation of adverse effects.


Asunto(s)
Antipsicóticos/farmacología , Isoxazoles/farmacología , Pirimidinas/farmacología , Risperidona/farmacología , Transducción de Señal/efectos de los fármacos , Adenilil Ciclasas/metabolismo , Animales , Antipsicóticos/química , Arrestinas/metabolismo , Células CHO , Cricetinae , Cricetulus , Agonistas de Dopamina/farmacología , Relación Dosis-Respuesta a Droga , Agonismo Inverso de Drogas , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Agonistas de los Receptores Histamínicos/farmacología , Humanos , Isoxazoles/química , Estructura Molecular , Palmitato de Paliperidona , Pirimidinas/química , Receptor de Serotonina 5-HT2A/efectos de los fármacos , Receptor de Serotonina 5-HT2A/genética , Receptor de Serotonina 5-HT2A/metabolismo , Receptor de Serotonina 5-HT2C/efectos de los fármacos , Receptor de Serotonina 5-HT2C/genética , Receptor de Serotonina 5-HT2C/metabolismo , Receptores de Dopamina D2/efectos de los fármacos , Receptores de Dopamina D2/genética , Receptores de Dopamina D2/metabolismo , Receptores Histamínicos H1/efectos de los fármacos , Receptores Histamínicos H1/genética , Receptores Histamínicos H1/metabolismo , Risperidona/química , Agonistas de Receptores de Serotonina/farmacología , Relación Estructura-Actividad , Transfección , beta-Arrestinas
3.
Tissue Antigens ; 72(5): 415-24, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18946929

RESUMEN

The non-classical major histocompatibility complex (MHC) class I molecule human leucocyte antigen (HLA)-E is the least polymorphic of all the MHC class I molecules and acts as a ligand for receptors of both the innate and the adaptive immune systems. The recognition of self-peptides complexed to HLA-E by the CD94-NKG2A receptor expressed by natural killer (NK) cells represents a crucial checkpoint for immune surveillance by NK cells. However, HLA-E can also be recognised by the T-cell receptor expressed by alphabeta CD8 T cells and therefore can play a role in the adaptive immune response to invading pathogens. The recent resolution of HLA-E in complex with both innate and adaptive ligands has provided insight into the dual role of this molecule in immunity.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Antígenos HLA/metabolismo , Antígenos de Histocompatibilidad Clase I/metabolismo , Células Asesinas Naturales/inmunología , Subfamília D de Receptores Similares a Lectina de las Células NK/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Linfocitos T CD8-positivos/metabolismo , Antígenos HLA/química , Antígenos HLA/inmunología , Trasplante de Células Madre Hematopoyéticas , Antígenos de Histocompatibilidad Clase I/química , Antígenos de Histocompatibilidad Clase I/inmunología , Humanos , Inmunidad Activa/inmunología , Inmunidad Innata/inmunología , Células Asesinas Naturales/metabolismo , Subfamília D de Receptores Similares a Lectina de las Células NK/inmunología , Polimorfismo Genético , Dominios y Motivos de Interacción de Proteínas/fisiología , Receptores de Antígenos de Linfocitos T/inmunología , Receptores de Células Asesinas Naturales/inmunología , Receptores de Células Asesinas Naturales/metabolismo , Antígenos HLA-E
4.
Am J Physiol Regul Integr Comp Physiol ; 281(3): R770-7, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11506991

RESUMEN

Pulmonary surfactant (PS), a mixture of phospholipids and proteins secreted by alveolar type II cells, functions to reduce the surface tension in the lungs of all air-breathing vertebrates. Here we examine the control of PS during lung development in a homeothermic egg-laying vertebrate. In mammals, glucocorticoids and autonomic neurotransmitters contribute to the maturation of the surfactant system. We examined whether dexamethasone, epinephrine, and carbamylcholine hydrochloride (agonist for acetylcholine) increased the amount of PS secreted from cultured type II cells of the developing chicken lung. In particular, we wanted to establish whether dexamethasone would increase PS secretion through a process involving lung fibroblasts. We isolated and cocultured type II cells and lung fibroblasts from chickens after 16, 18, and 20 days of incubation and from hatchlings (day 21). Epinephrine stimulated phosphatidylcholine (PC) secretion at all stages, whereas dexamethasone stimulated secretion of PC at days 16 and 18. Carbamylcholine hydrochloride had no effect at any stage. This is the first study to establish the existence of similar cellular pathways regulating the development of surfactant in chickens and eutherian mammals, despite the vastly different birthing strategies and lung structure and function.


Asunto(s)
Dexametasona/farmacología , Epinefrina/farmacología , Alveolos Pulmonares/efectos de los fármacos , Alveolos Pulmonares/metabolismo , Surfactantes Pulmonares/metabolismo , Agonistas Adrenérgicos/farmacología , Animales , Carbacol/farmacología , Supervivencia Celular , Células Cultivadas , Embrión de Pollo , Pollos , Agonistas Colinérgicos/farmacología , Técnicas de Cocultivo , Medios de Cultivo Condicionados/química , Relación Dosis-Respuesta a Droga , Fibroblastos/metabolismo , Fibroblastos/ultraestructura , Glucocorticoides/farmacología , L-Lactato Deshidrogenasa/análisis , Microscopía Electrónica , Fosfatidilcolinas/análisis , Fosfatidilcolinas/metabolismo , Alveolos Pulmonares/ultraestructura , Factores de Tiempo
5.
Physiol Biochem Zool ; 74(4): 493-501, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11436133

RESUMEN

Pulmonary surfactant, consisting predominantly of phosphatidylcholine (PC), is secreted from Type II cells into the lungs of all air-breathing vertebrates, where it functions to reduce surface tension. In mammals, glucocorticoids and thyroid hormones contribute to the maturation of the surfactant system. It is possible that phylogeny, lung structure, and the environment may influence the development of the surfactant system. Here, we investigate the ontogeny of PC secretion from cocultured Type II cells and fibroblasts in the sea turtle, Chelonia mydas, following 58, 62, and 73 d of incubation and after hatching. The influence of glucocorticoids and thyroid hormones on PC secretion was also examined. Basal PC secretion was lowest at day 58 (3%) and reached a maximal secretion rate of 10% posthatch. Dexamethasone (Dex) alone stimulated PC secretion only at day 58. Triiodothyronine (T(3)) stimulated PC secretion in cells isolated from days 58 and 73 embryos and from hatchling turtles. A combination of Dex and T(3) stimulated PC secretion at all time points.


Asunto(s)
Pulmón/metabolismo , Fosfatidilcolinas/metabolismo , Surfactantes Pulmonares/metabolismo , Tortugas/embriología , Tortugas/fisiología , Animales , Peso Corporal , Técnicas de Cocultivo , Dexametasona/farmacología , Glucocorticoides/farmacología , Pulmón/citología , Pulmón/embriología , Masculino , Microscopía Electrónica/veterinaria , Tamaño de los Órganos , Fosfatidilcolinas/análisis , Surfactantes Pulmonares/análisis , Triyodotironina/farmacología
7.
J Mol Evol ; 46(2): 131-8, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9452514

RESUMEN

Surface tension is reduced at the air-liquid interface in the lung by a mixture of lipids and proteins termed pulmonary surfactant. This study is the first to provide evidence for the presence of a surfactant-specific protein (Surfactant Protein A-SP-A) in the gas-holding structures of representatives of all the major vertebrate groups. Western blot analysis demonstrated cross-reactivity between an antihuman SP-A antibody and material lavaged from lungs or swimbladders of members from all vertebrate groups. Immunocytochemistry localized this SP-A-like protein to the air spaces of lungs from the actinopterygiian fish and lungfish. Northern blot analysis indicated that regions of the mouse SP-A cDNA sequence are complementary to lung mRNA from all species examined. The presence of an SP-A-like protein and SP-A mRNA in members of all the major vertebrate groups implies that the surfactant system had a single evolutionary origin in the vertebrates. Moreover, the evolution of the surfactant system must have been a prerequisite for the evolution of airbreathing. The presence of SP-A in the goldfish swimbladder demonstrates a role for the surfactant system in an organ that is no longer used for airbreathing.


Asunto(s)
Evolución Molecular , Pulmón/metabolismo , Proteolípidos/fisiología , Surfactantes Pulmonares/fisiología , Vertebrados , Animales , Northern Blotting , Western Blotting , Humanos , Inmunohistoquímica , Proteína A Asociada a Surfactante Pulmonar , Proteínas Asociadas a Surfactante Pulmonar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...